Revive Therapeutics Ltd (RVVTF)

[powerbattles]

PAY ATTENTION TO COMPANY'S CATALYSTS BELOW:

UPGRADE OCQB

Select hospital locations U.S trials.

Sponsor for Trials

IND FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19

FDA Authorized emergency IND (eIND

Grant/Funding opportunities

Phase 3 clinical trials Bucillamine in the treatment of COVID-19 in the U.S

Expand Phase 3 Clinical Trials COVID-19 in Asia-Pacific and Canada

Q2 Submit IND for Phase 2 clinical study of CBD in the treatment of Autoimmune Hepatitis

Q2/3 Pre-IND meeting with FDA for Bucillamine in various infectious diseases (undisclosed)

Update the final Prototype orally dissolvable thin film strip for psilocybin

Patents approval process psilocybin formulations

Finalize vendor agreements in project management, medical monitoring, and data management.

Patent approval News Updates:



Q3 Initiate Phase 2 clinical study of CBD in the treatment of Autoimmune Hepatitis

Q3 Pre-IND meeting with FDA for Psilocybin (undisclosed indications)

Q3/4 Results from Phase 3 clinical study of Bucillamine in the treatment of COVID-19

Q4 Results from Phase 2 clinical study of CBD in the treatment of Autoimmune Hepatitis

Potential buyout could be Billions for a biotech company

Manufacturing deal Atwill Medical Solutions CEO is on the Revive board just signed a deal with VXRT This could lead to potential partnership/deals in the future. IMHO:))

Update on its Psilocybin-Based Pharmaceutical Program

Partners to Advance Research for Psilocybin-Based Pharmaceutical Products

Update drugs research partnership agreement (“SRPA”) with the University of Wisconsin-Madison

Link to Revive's subsidiary company

https://www.psilocinpharma.com/